Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Stroke

  Free Subscription


Articles published in Int J Cardiol

Retrieve available abstracts of 195 articles:
HTML format
Text format



Single Articles


    April 2018
  1. SHENG X, Ding S, Ge H, Sun Y, et al
    Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
    Int J Cardiol. 2018 Apr 25. pii: S0167-5273(17)37021.
    PubMed     Text format     Abstract available


    March 2018
  2. MUJOVIC N, Potpara TS
    Optimizing bleeding risk assessment in patients with atrial fibrillation: To score or not to score?
    Int J Cardiol. 2018;254:164-166.
    PubMed     Text format    


    February 2018
  3. GOETTE A
    Atrial fibrillation and stroke risk factors induce decline in creatinine clearance: Is there a specific "fibrillatory kidney disease"?
    Int J Cardiol. 2018;253:82-83.
    PubMed     Text format    


  4. FAUCHIER L, Bisson A, Genet T
    Antiplatelet therapy, vitamin K antagonist and low time in therapeutic range in patients with atrial fibrillation: Highway to bleed.
    Int J Cardiol. 2018;252:110-111.
    PubMed     Text format    


    January 2018
  5. QIN F, Liu N, Liu C, Bai F, et al
    Could excessive atrial ectopic activity be an independent risk factor for ischemic stroke?
    Int J Cardiol. 2018;251:53.
    PubMed     Text format    


  6. BAI R
    Percutaneous left atrial appendage closure versus oral anticoagulant: A bird in the hand is worth two in the bush?
    Int J Cardiol. 2018;251:51-52.
    PubMed     Text format    


  7. WAKABAYASHI K, Ikeda N, Kajimoto K, Minami Y, et al
    Trends and predictors of non-cardiovascular death in patients hospitalized for acute heart failure.
    Int J Cardiol. 2018;250:164-170.
    PubMed     Text format     Abstract available


    December 2017
  8. WONG CX
    Atrial fibrillation, hip fracture, and oral anticoagulation therapy.
    Int J Cardiol. 2017;249:260.
    PubMed     Text format    


  9. CERIT L
    Atrial fibrillation, hip fracture, and oral anticoagulant therapy.
    Int J Cardiol. 2017;249:259.
    PubMed     Text format    


  10. GOETTE A
    Why is there still undertreatment with oral anticoagulants in elderly high risk patients with AF?
    Int J Cardiol. 2017;249:247-248.
    PubMed     Text format    


    November 2017
  11. MAKOWSKI M, Baj Z
    New biomarkers in risk stratification in patients with atrial fibrillation.
    Int J Cardiol. 2017;247:19.
    PubMed     Text format    


  12. BARKAS F, Elisaf M, Liberopoulos E
    Low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores for the prediction of new-onset atrial fibrillation.
    Int J Cardiol. 2017;247:18.
    PubMed     Text format    


  13. QIN F, Zhao Y, He B, Liu Q, et al
    Could low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores in predicting new atrial fibrillation?
    Int J Cardiol. 2017;247:17.
    PubMed     Text format    


  14. EL-BATTRAWY I, Borggrefe M, Akin I
    Atrial fibrillation as a risk factor for worse outcome in acute coronary syndrome.
    Int J Cardiol. 2017;246:53.
    PubMed     Text format    


    October 2017
  15. WIYEH AB, Ochodo EA, Wiysonge CS, Kakia A, et al
    A systematic review of the efficacy and safety of intrapericardial fibrinolysis in patients with pericardial effusion.
    Int J Cardiol. 2017 Oct 26. pii: S0167-5273(17)35919.
    PubMed     Text format     Abstract available


  16. PAGOLA J, Juega J, Francisco-Pascual J, Moya A, et al
    Yield of atrial fibrillation detection with Textile Wearable Holter from the acute phase of stroke: Pilot study of Crypto-AF registry.
    Int J Cardiol. 2017 Oct 22. pii: S0167-5273(17)33896.
    PubMed     Text format     Abstract available


  17. TSE G, Lip GYH, Liu T
    The CHADS2 and CHA2DS2-VASc scores for predicting healthcare utilization and outcomes: Observations on the Appropriate Use and Misuse of Risk scores.
    Int J Cardiol. 2017;245:181-182.
    PubMed     Text format    


  18. WANG S, Li J, Yan G, Zhang Y, et al
    New biomarkers' improvement of thrombogenesis risk stratification in patients with atrial fibrillation and CHA2DS2-VASc Score 1.
    Int J Cardiol. 2017;244:296.
    PubMed     Text format    


    September 2017
  19. DENAS G, Gennaro N, Ferroni E, Fedeli U, et al
    Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naive patients with non-valvular atrial fibrillation: Propensity score matched cohort study.
    Int J Cardiol. 2017 Sep 18. pii: S0167-5273(17)32377.
    PubMed     Text format     Abstract available


  20. SAMBOLA A, Ruiz-Meana M, Barba I, Del Blanco BG, et al
    Glycative and oxidative stress are associated with altered thrombus composition in diabetic patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2017;243:9-14.
    PubMed     Text format     Abstract available


  21. TOCCI G, Presta V
    Increased arterial stiffness and haemorrhagic transformation in ischaemic stroke after thrombolysis: A new marker of risk for cerebrovascular events and complications.
    Int J Cardiol. 2017;243:471-472.
    PubMed     Text format    


  22. ACAMPA M, Camarri S, Lazzerini PE, Guideri F, et al
    Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis.
    Int J Cardiol. 2017;243:466-470.
    PubMed     Text format     Abstract available


  23. AYUBI E, Safiri S
    Comments on CHA2DS2-VASc score in the prediction of ischemic bowel disease among patients with atrial fibrillation.
    Int J Cardiol. 2017;242:9.
    PubMed     Text format    


  24. HU WS, Lin CL
    Reply: CHA2DS2-VASc score in the prediction of ischemic bowel disease among patients with atrial fibrillation: Insights from a nationwide cohort.
    Int J Cardiol. 2017;242:10.
    PubMed     Text format    


    July 2017
  25. ROSSELLO X, Huo Y, Pocock S, de Werf FV, et al
    Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality.
    Int J Cardiol. 2017 Jul 15. pii: S0167-5273(17)32845.
    PubMed     Text format     Abstract available


  26. CERIT L
    Dual risk stratification for dual antiplatelet therapy: SYNTAX and CHA2DS2-VASc score.
    Int J Cardiol. 2017;239:22.
    PubMed     Text format    


  27. NOSEWORTHY PA, Yao X, Gersh BJ, Hargraves I, et al
    Long-term stroke and bleeding risk in patients with atrial fibrillation treated with oral anticoagulants in contemporary practice: Providing evidence for shared decision-making.
    Int J Cardiol. 2017 Jul 14. pii: S0167-5273(17)32969.
    PubMed     Text format     Abstract available


    June 2017
  28. LAVI S, Iqbal J, Cairns JA, Cantor WJ, et al
    Bare metal versus drug eluting stents for ST-segment elevation myocardial infarction in the TOTAL trial.
    Int J Cardiol. 2017 Jun 29. pii: S0167-5273(17)33508.
    PubMed     Text format     Abstract available


  29. VIDALE S, Arnaboldi M, Bosio V, Corrado G, et al
    Short-term air pollution exposure and cardiovascular events: A 10-year study in the urban area of Como, Italy.
    Int J Cardiol. 2017 Jun 15. pii: S0167-5273(17)31683.
    PubMed     Text format     Abstract available


  30. CAPPELLARI M, Bovi P
    Direct oral anticoagulants in patients with cervical artery dissection and cerebral venous thrombosis. A case series and review of the literature.
    Int J Cardiol. 2017 Jun 13. pii: S0167-5273(17)32629.
    PubMed     Text format     Abstract available


  31. HOLDA MK, Koziej M, Wszolek K, Pawlik W, et al
    Left atrial accessory appendages, diverticula, and left-sided septal pouch in multi-slice computed tomography. Association with atrial fibrillation and cerebrovascular accidents.
    Int J Cardiol. 2017 Jun 13. pii: S0167-5273(17)32424.
    PubMed     Text format     Abstract available


  32. ZIEGLER PD, Rogers JD, Ferreira SW, Nichols AJ, et al
    Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population.
    Int J Cardiol. 2017 Jun 10. pii: S0167-5273(17)32506.
    PubMed     Text format     Abstract available


  33. CARMO J, Ferreira J, Costa F, Carmo P, et al
    Non-vitamin K antagonist oral anticoagulants compared with warfarin at different levels of INR control in atrial fibrillation: A meta-analysis of randomized trials.
    Int J Cardiol. 2017 Jun 3. pii: S0167-5273(17)31600.
    PubMed     Text format     Abstract available


  34. ACHILLES A, Mohring A, Dannenberg L, Piayda K, et al
    Analgesic medication with dipyrone in patients with coronary artery disease: Relation to MACCE.
    Int J Cardiol. 2017;236:76-81.
    PubMed     Text format     Abstract available


  35. MEFFORD M, Safford MM, Muntner P, Durant RW, et al
    Insurance, self-reported medication adherence and LDL cholesterol: The REasons for Geographic And Racial Differences in Stroke study.
    Int J Cardiol. 2017;236:462-465.
    PubMed     Text format     Abstract available


  36. CHAIKRIANGKRAI K, Jhun HY, Palamaner Subash Shantha G, Bin Abdulhak A, et al
    Coronary artery calcium score as a predictor for incident stroke: Systematic review and meta-analysis.
    Int J Cardiol. 2017;236:473-477.
    PubMed     Text format     Abstract available


    May 2017
  37. MATUSIK PT, Matusik PS, Kornacewicz-Jach Z, Malecka B, et al
    Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.
    Int J Cardiol. 2017 May 16. pii: S0167-5273(17)31785.
    PubMed     Text format     Abstract available


  38. BECATTINI C, Franco L, Agnelli G
    Risk of death in patients with major bleedings while on treatment with oral anticoagulants.
    Int J Cardiol. 2017;235:200.
    PubMed     Text format    


  39. ALEXOPOULOS D
    Delayed onset of novel P2Y12 receptor antagonists action post fibrinolysis.
    Int J Cardiol. 2017;234:131.
    PubMed     Text format    


  40. SUZUKI M, Takanashi S
    Assessment of clinical severity in patients with infective endocarditis with cardio-embolic strokes.
    Int J Cardiol. 2017;234:140.
    PubMed     Text format    


    April 2017
  41. KWOK CS, Bagur R, Rashid M, Lavi R, et al
    Aortic stenosis and non-cardiac surgery: A systematic review and meta-analysis.
    Int J Cardiol. 2017 Apr 12. pii: S0167-5273(16)34897.
    PubMed     Text format     Abstract available


    March 2017
  42. SHEN L, Song L, Liu B, Li H, et al
    Effects of early age at natural menopause on coronary heart disease and stroke in Chinese women.
    Int J Cardiol. 2017 Mar 30. pii: S0167-5273(16)33287.
    PubMed     Text format     Abstract available


  43. KAIER K, Reinecke H, Schmoor C, Frankenstein L, et al
    Learning Curves Among All Patients Undergoing Transcatheter Aortic Valve Implantation in Germany: A Retrospective Observational Study.
    Int J Cardiol. 2017 Mar 2. pii: S0167-5273(17)31288.
    PubMed     Text format     Abstract available


  44. KLAER J, Mahler A, Scherbakov N, Klug L, et al
    Longer-term impact of hemiparetic stroke on skeletal muscle metabolism-A pilot study.
    Int J Cardiol. 2017;230:241-247.
    PubMed     Text format     Abstract available


    February 2017
  45. PROIETTI M, Lip GY
    Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trials.
    Int J Cardiol. 2017 Feb 27. pii: S0167-5273(17)30411.
    PubMed     Text format     Abstract available


  46. LEE SR, Choi EK, Han KD, Cha MJ, et al
    Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA2DS2-VASc score in the entire Korean population.
    Int J Cardiol. 2017 Feb 13. pii: S0167-5273(16)34726.
    PubMed     Text format     Abstract available


  47. GUIMARAES LF, Stone GW, Caixeta A
    Reply: Delayed onset of novel P2Y12 receptor antagonists action post fibrinolysis.
    Int J Cardiol. 2017 Feb 11. pii: S0167-5273(17)30775.
    PubMed     Text format    


  48. MASUDA K, Ishizu T, Niwa K, Takechi F, et al
    Increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias.
    Int J Cardiol. 2017 Feb 5. pii: S0167-5273(17)30680.
    PubMed     Text format     Abstract available


  49. MODI R, Patted SV, Halkati PC, Porwal S, et al
    CHA2DS2-VASc-HSF score - New predictor of severity of coronary artery disease in 2976 patients.
    Int J Cardiol. 2017;228:1002-1006.
    PubMed     Text format     Abstract available


  50. YUAN X, Du J, Liu Q, Zhang L, et al
    Defining the role of perioperative statin treatment in patients after cardiac surgery: A meta-analysis and systematic review of 20 randomized controlled trials.
    Int J Cardiol. 2017;228:958-966.
    PubMed     Text format     Abstract available


    January 2017
  51. VEDOVATI MC, Verdecchia P, Giustozzi M, Molini G, et al
    Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2017 Jan 19. pii: S0167-5273(16)34180.
    PubMed     Text format     Abstract available


  52. KO D, Thigpen JL, Otis JA, Forster K, et al
    Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillation.
    Int J Cardiol. 2017;227:808-812.
    PubMed     Text format     Abstract available


  53. SUZUKI M, Takanashi S, Ohshima Y, Nagatomo Y, et al
    Critical potential of early cardiac surgery for infective endocarditis with cardio-embolic strokes.
    Int J Cardiol. 2017;227:222-224.
    PubMed     Text format     Abstract available


    December 2016
  54. GUIMARAES LF, Genereux P, Silveira D, Pesaro AE, et al
    P2Y12 receptor inhibition with prasugrel and ticagrelor in STEMI patients after fibrinolytic therapy: Analysis from the SAMPA randomized trial.
    Int J Cardiol. 2016 Dec 27. pii: S0167-5273(16)34824.
    PubMed     Text format     Abstract available


  55. MUSCOGIURI G, Annweiler C, Duval G, Karras S, et al
    Vitamin D and cardiovascular disease: From atherosclerosis to myocardial infarction and stroke.
    Int J Cardiol. 2016 Dec 26. pii: S0167-5273(16)34541.
    PubMed     Text format     Abstract available


  56. KAHLERT P, Hildebrandt HA, Patsalis PC, Al-Rashid F, et al
    No protection of heart, kidneys and brain by remote ischemic preconditioning before transfemoral transcatheter aortic valve implantation: Interim-analysis of a randomized single-blinded, placebo-controlled, single-center trial.
    Int J Cardiol. 2016 Dec 6. pii: S0167-5273(16)33752.
    PubMed     Text format     Abstract available


    November 2016
  57. LEE CH, Lin TY, Chang SH, Chen CH, et al
    Body mass index is an independent predictor of major bleeding in non-valvular atrial fibrillation patients taking dabigatran.
    Int J Cardiol. 2016;228:771-778.
    PubMed     Text format     Abstract available


  58. WYBRANIEC MT, Faryan M, Kusz B, Lasek-Bal A, et al
    CHA2DS2-VASC-AF2 score accurately predicts moderate-to-severe acute neurological dysfunction in the course of first ever ischaemic stroke.
    Int J Cardiol. 2016;228:286-288.
    PubMed     Text format    


  59. WONG CK
    Simplifying electrocardiographic assessment in STEMI reperfusion management: Pros and cons.
    Int J Cardiol. 2016;227:30-36.
    PubMed     Text format     Abstract available


  60. SASAI M, Iso Y, Mizukami T, Tomosugi N, et al
    Potential contribution of the hepcidin-macrophage axis to plaque vulnerability in acute myocardial infarction in human.
    Int J Cardiol. 2016;227:114-121.
    PubMed     Text format     Abstract available


  61. BECATTINI C, Franco L, Beyer-Westendorf J, Masotti L, et al
    Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33576.
    PubMed     Text format     Abstract available


  62. ZHOU X, Cao K, Kou S, Qu S, et al
    Usefulness of CHADS2 score for prognostic stratification of patients with coronary artery disease: A systematic review and meta-analysis of cohort studies.
    Int J Cardiol. 2016;228:906-911.
    PubMed     Text format     Abstract available


  63. ZHU W, Fu L, Ding Y, Huang L, et al
    Meta-analysis of ATRIA versus CHA2DS2-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33445.
    PubMed     Text format     Abstract available


  64. GUIMARAES PO, Wojdyla DM, Alexander JH, Thomas L, et al
    Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial.
    Int J Cardiol. 2016 Nov 7. pii: S0167-5273(16)33444.
    PubMed     Text format     Abstract available


    October 2016
  65. NAVARESE EP, Kolodziejczak M, Winter MP, Alimohammad A, et al
    Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study.
    Int J Cardiol. 2016 Oct 29. pii: S0167-5273(16)33272.
    PubMed     Text format     Abstract available


    September 2016
  66. SCHMIDT M, Ulrichsen SP, Pedersen L, Botker HE, et al
    30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death.
    Int J Cardiol. 2016;225:30-36.
    PubMed     Text format     Abstract available


  67. CHUGH Y, Faillace RT
    The C of CHADS: Historical perspective and clinical applications for anticoagulation in patients with non valvular atrial fibrillation and congestive heart failure.
    Int J Cardiol. 2016;224:431-436.
    PubMed     Text format     Abstract available


  68. RUSSO V, Di Napoli L, Bianchi V, Tavoletta V, et al
    A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience.
    Int J Cardiol. 2016;224:454-455.
    PubMed     Text format    


  69. INDRARATNA P, Tian DH, Yan TD, Doyle MP, et al
    Transcatheter aortic valve implantation versus surgical aortic valve replacement: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2016;224:382-387.
    PubMed     Text format     Abstract available


  70. AKCAY M, Soylu K, Yanik A
    Acute thrombotic left main coronary artery; treatment with low dose slow infusion tPA.
    Int J Cardiol. 2016;224:265-266.
    PubMed     Text format    


  71. TAKEUCHI D, Inai K, Shinohara T, Nakanishi T, et al
    Blood coagulation abnormalities and the usefulness of D-dimer level for detecting intracardiac thrombosis in adult Fontan patients.
    Int J Cardiol. 2016;224:139-144.
    PubMed     Text format     Abstract available


    August 2016
  72. KATZ M, Bosworth HB, Lopes RD, Dupre ME, et al
    A time-series analysis of the relation between unemployment rate and hospital admission for acute myocardial infarction and stroke in Brazil over more than a decade.
    Int J Cardiol. 2016;224:33-36.
    PubMed     Text format     Abstract available


  73. DZIEWIERZ A, Siudak Z, Tokarek T, Rakowski T, et al
    Determinants of stroke following percutaneous coronary intervention in acute myocardial infarction (from ORPKI Polish National Registry).
    Int J Cardiol. 2016;223:236-238.
    PubMed     Text format    


  74. SANI M, Ayubi E, Mansori K, Khazaei S, et al
    Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation: Methodological issues of prediction models.
    Int J Cardiol. 2016;222:949.
    PubMed     Text format    


  75. HUMBERT X, Roule V, Chequel M, Fedrizzi S, et al
    Non-vitamin K oral anticoagulant treatment in elderly patients with atrial fibrillation and coronary heart disease.
    Int J Cardiol. 2016 Aug 4. pii: S0167-5273(16)31605.
    PubMed     Text format     Abstract available


  76. HUGO GS, Figueiras-Graillet LM, Anguita M, Marin F, et al
    Oral anticoagulation in octogenarians with atrial fibrillation.
    Int J Cardiol. 2016;223:87-90.
    PubMed     Text format     Abstract available


  77. BEDEIR K, Giugliano RP, Ramlawi B
    Chronic anticoagulation in non-valvular atrial fibrillation: Where things stand.
    Int J Cardiol. 2016;222:615-619.
    PubMed     Text format     Abstract available


  78. KIM Y, Lee SH
    Embolic stroke and after-admission atrial fibrillation.
    Int J Cardiol. 2016;222:576-580.
    PubMed     Text format     Abstract available


  79. ERGUN G, Basaran O, Dogan V, Dogan MM, et al
    Obesity and atrial fibrillation.
    Int J Cardiol. 2016;223:159-160.
    PubMed     Text format    


  80. ELGENDY IY, Mahmoud AN, Mansoor H, Mojadidi MK, et al
    Evolution of acute ischemic stroke therapy from lysis to thrombectomy: Similar or different to acute myocardial infarction?
    Int J Cardiol. 2016;222:441-447.
    PubMed     Text format     Abstract available


  81. CANOY D, Cairns BJ, Balkwill A, Wright FL, et al
    Hypertension in pregnancy and risk of coronary heart disease and stroke: A prospective study in a large UK cohort.
    Int J Cardiol. 2016;222:1012-1018.
    PubMed     Text format     Abstract available


    July 2016
  82. SAITO I, Yamagishi K, Kokubo Y, Yatsuya H, et al
    Association between mortality and incidence rates of coronary heart disease and stroke: The Japan Public Health Center-based prospective (JPHC) study.
    Int J Cardiol. 2016;222:281-286.
    PubMed     Text format     Abstract available


  83. PATZER J, Oqab Z, McIntyre WF, Hopman WM, et al
    Cardiology residents' anticoagulation preferences for stroke prophylaxis in atrial fibrillation patients.
    Int J Cardiol. 2016;223:63-64.
    PubMed     Text format    


  84. ENGDAHL J, Holmen A, Svennberg E, Friberg L, et al
    Geographic and socio-demographic differences in uptake of population-based screening for atrial fibrillation: The STROKESTOP I study.
    Int J Cardiol. 2016;222:430-435.
    PubMed     Text format     Abstract available


  85. GARG L, Chen C, Haines DE
    Atrial fibrillation and chronic kidney disease requiring hemodialysis - Does warfarin therapy improve the risks of this lethal combination?
    Int J Cardiol. 2016;222:47-50.
    PubMed     Text format     Abstract available


  86. SENOO K, Lip GY
    Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial.
    Int J Cardiol. 2016;221:379-382.
    PubMed     Text format     Abstract available


    June 2016
  87. PAGNESI M, Martino EA, Chiarito M, Mangieri A, et al
    Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis.
    Int J Cardiol. 2016;221:97-106.
    PubMed     Text format     Abstract available


  88. CHOI EJ, Lee IH, Je NK
    Inadequate stroke prevention in Korean atrial fibrillation patients in the post-warfarin era.
    Int J Cardiol. 2016;220:647-652.
    PubMed     Text format     Abstract available


  89. PALOMAKI A, Kiviniemi T, Mustonen P, Odei C, et al
    Mortality after stroke in patients with paroxysmal and chronic atrial fibrillation - The FibStroke study.
    Int J Cardiol. 2016 Jun 23. pii: S0167-5273(16)31117.
    PubMed     Text format     Abstract available


  90. XIA SJ, Du X, Li C, Wu JH, et al
    Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study.
    Int J Cardiol. 2016;220:284-289.
    PubMed     Text format     Abstract available


  91. ROKOS J, Heger M, Stollberger C, Finsterer J, et al
    Bipolar disorder, ischemic stroke, mitral valve vegetation and recurrent venous thrombosis due to antiphospholipid syndrome despite rivaroxaban.
    Int J Cardiol. 2016;221:383-384.
    PubMed     Text format    


  92. RICCI RP, Vaccari D, Morichelli L, Zanotto G, et al
    Stroke incidence in patients with cardiac implantable electronic devices remotely controlled with automatic alerts of atrial fibrillation. A sub-analysis of the HomeGuide study.
    Int J Cardiol. 2016;219:251-256.
    PubMed     Text format     Abstract available


  93. COLANTONIO LD, Gamboa CM, Kleindorfer DO, Carson AP, et al
    Stroke symptoms and risk for incident coronary heart disease in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    Int J Cardiol. 2016;220:122-128.
    PubMed     Text format     Abstract available


    May 2016
  94. TONG Y, Cai L, Zhang YW, Lin L, et al
    Role of functional polymorphisms of the IL-10 gene promoter in the risk of ischemic stroke in Chinese Uyghur population: One case-control study.
    Int J Cardiol. 2016;211:58-60.
    PubMed     Text format    


    April 2016
  95. RICCI F, Di Castelnuovo A, Savarese G, Perrone Filardi P, et al
    ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure - A network meta-analysis.
    Int J Cardiol. 2016;217:128-134.
    PubMed     Text format     Abstract available


  96. STOLLBERGER C, Finsterer J, Schneider B
    Is left atrial appendage closure useful for stroke prevention in atrial fibrillation patients with renal failure?
    Int J Cardiol. 2016;216:186-187.
    PubMed     Text format    


  97. ALBERTS MJ, Peacock WF, Fields LE, Bunz TJ, et al
    Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke.
    Int J Cardiol. 2016;215:11-13.
    PubMed     Text format    


  98. XIE XX, Liu P, Wan FY, Lin SG, et al
    Blood pressure lowering and stroke events in type 2 diabetes: A network meta-analysis of randomized controlled trials.
    Int J Cardiol. 2016;208:141-6.
    PubMed     Text format    


    March 2016
  99. KOUNIS NG, Grapsas N, Soufras GD, Lianas D, et al
    Clinical and subclinical leaflet thrombosis in bioprosthetic aortic valves: A manifestation of Kounis syndrome?
    Int J Cardiol. 2016;214:86-87.
    PubMed     Text format    


  100. EFTEKHARI A, Damgaard D, Grove EL
    Fatal stroke following treatment with apixaban in a patient with atrial fibrillation and left atrial appendage thrombus.
    Int J Cardiol. 2016;214:131-132.
    PubMed     Text format    


  101. WATANABE E, Yamamoto M, Kodama I, Inoue H, et al
    Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry.
    Int J Cardiol. 2016;212:311-317.
    PubMed     Text format     Abstract available


  102. COLEMAN CI, Tangirala M, Evers T
    Medication adherence to rivaroxaban and dabigatran for stroke prevention in patients with non-valvular atrial fibrillation in the United States.
    Int J Cardiol. 2016;212:171-173.
    PubMed     Text format    


  103. TONG Y, Huang X, Wang Z, Han S, et al
    Effects of functional genetic variants in PPARdelta encoding peroxisome proliferator-activated receptor delta on the risk of ischemic stroke in Chinese Han population.
    Int J Cardiol. 2016;207:297-9.
    PubMed     Text format    


  104. DELLBORG M, Eriksson P
    Randomized trials of closure of persistent foramen ovale (PFO) vs medical therapy for patients with cryptogenic stroke - Effect of lost-to-follow-up and withdrawal of consent.
    Int J Cardiol. 2016;207:308-9.
    PubMed     Text format    


    February 2016
  105. YIP HK, Yuen CM, Chen KH, Chai HT, et al
    Tissue plasminogen activator deficiency preserves neurological function and protects against murine acute ischemic stroke.
    Int J Cardiol. 2016;205:133-41.
    PubMed     Text format     Abstract available


  106. SEO WK, Kang SH, Jung JM, Choi JY, et al
    Novel composite score to predict atrial Fibrillation in acute stroke patients: AF predicting score in acute stroke.
    Int J Cardiol. 2016;209:184-189.
    PubMed     Text format     Abstract available


  107. MELGAARD L, Gorst-Rasmussen A, Sogaard P, Rasmussen LH, et al
    Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation.
    Int J Cardiol. 2016;209:1-6.
    PubMed     Text format     Abstract available


  108. LEE YB, Jeong SW, Rhee MY, Leem CH, et al
    Aorta-to-arm pulse wave transit time ratio: Better prediction of coronary artery disease and stroke than pulse wave velocity.
    Int J Cardiol. 2016;204:1-3.
    PubMed     Text format    


    January 2016
  109. CHHABRA L
    Importance of P-wave indices in stroke.
    Int J Cardiol. 2016;203:962-3.
    PubMed     Text format    


  110. LEE YJ, Park JK, Uhm JS, Kim JY, et al
    Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy.
    Int J Cardiol. 2016;203:372-8.
    PubMed     Text format     Abstract available


  111. KEFER J, Tzikas A, Freixa X, Shakir S, et al
    Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Int J Cardiol. 2016;207:335-340.
    PubMed     Text format     Abstract available


  112. PANG J, Zhang Z, Zheng TZ, Bassig BA, et al
    Green tea consumption and risk of cardiovascular and ischemic related diseases: A meta-analysis.
    Int J Cardiol. 2016;202:967-74.
    PubMed     Text format     Abstract available


  113. MAR PL, Familtsev D, Ezekowitz MD, Lakkireddy D, et al
    Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and procedures.
    Int J Cardiol. 2016;202:578-85.
    PubMed     Text format     Abstract available


    December 2015
  114. CHEN YL, Tsai TH, Wallace CG, Chen YL, et al
    Intra-carotid arterial administration of autologous peripheral blood-derived endothelial progenitor cells improves acute ischemic stroke neurological outcomes in rats.
    Int J Cardiol. 2015;201:668-83.
    PubMed     Text format     Abstract available


  115. KANAI M, Kubo H, Kitamura Y, Izawa KP, et al
    Difference in autonomic nervous activity in different subtypes of noncardioembolic ischemic stroke.
    Int J Cardiol. 2015;201:171-3.
    PubMed     Text format    


  116. GUO X, Li Z, Sun G, Guo L, et al
    Comparison of four nontraditional lipid profiles in relation to ischemic stroke among hypertensive Chinese population.
    Int J Cardiol. 2015;201:123-5.
    PubMed     Text format    


  117. TIAN L, Qiu H, Pun VC, Ho KF, et al
    Carbon monoxide and stroke: A time series study of ambient air pollution and emergency hospitalizations.
    Int J Cardiol. 2015;201:4-9.
    PubMed     Text format     Abstract available


    November 2015
  118. GARG J, Chaudhary R, Krishnamoorthy P, Shah N, et al
    Safety and efficacy of uninterrupted periprocedural rivaroxaban in patients undergoing atrial fibrillation catheter ablation: A metaanalysis of 1,362 patients.
    Int J Cardiol. 2015;203:906-908.
    PubMed     Text format    


  119. MEYER ML, Jaensch A, Mons U, Breitling LP, et al
    Atrial fibrillation and long-term prognosis of patients with stable coronary heart disease: Relevance of routine electrocardiogram.
    Int J Cardiol. 2015;203:1014-1015.
    PubMed     Text format    


  120. KONNO S, Munakata M
    High-density lipoprotein cholesterol might be a better predictor of stroke than other lipid measures in the general Japanese population: The Watari study.
    Int J Cardiol. 2015;203:874-876.
    PubMed     Text format    


  121. MARCUCCI M, Skjoth F, Lip GY, Iorio A, et al
    A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation.
    Int J Cardiol. 2015;203:785-790.
    PubMed     Text format     Abstract available


  122. YANG Y, Liu Q, Wu Z, Li X, et al
    Is hyperuricemia a recognizable biomarker for low risk of stroke in patients with atrial fibrillation?
    Int J Cardiol. 2015;203:624-625.
    PubMed     Text format    


  123. PIRINEN J, Putaala J, Aro AL, Surakka I, et al
    Resting 12-lead electrocardiogram reveals high-risk sources of cardioembolism in young adult ischemic stroke.
    Int J Cardiol. 2015;198:196-200.
    PubMed     Text format     Abstract available


    October 2015
  124. EYUBOGLU M
    Inadequate anticoagulation by Vitamin K antagonists and major adverse cardiovascular events other than stroke.
    Int J Cardiol. 2015 Oct 30. pii: S0167-5273(15)30553.
    PubMed     Text format    


  125. PALOMAKI A, Mustonen P, Hartikainen JE, Nuotio I, et al
    Strokes after cardioversion of atrial fibrillation - The FibStroke study.
    Int J Cardiol. 2015;203:269-273.
    PubMed     Text format    


  126. GARGIULO G, Capodanno D, Sannino A, Barbanti M, et al
    New-onset atrial fibrillation and increased mortality after transcatheter aortic valve implantation: A causal or spurious association?
    Int J Cardiol. 2015;203:264-266.
    PubMed     Text format    


  127. LIN YS, Tung TH, Wang J, Chen YF, et al
    Peripheral arterial disease and atrial fibrillation and risk of stroke, heart failure hospitalization and cardiovascular death: A nationwide cohort study.
    Int J Cardiol. 2015;203:204-211.
    PubMed     Text format     Abstract available


  128. PASTORI D, Pignatelli P, Saliola M, Carnevale R, et al
    Reply to: "Inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke".
    Int J Cardiol. 2015 Oct 17. pii: S0167-5273(15)30687.
    PubMed     Text format    


  129. ZHOU X, Zhang W, Lv W, Zhou Q, et al
    Left atrial appendage occlusion in atrial fibrillation for stroke prevention: A systemic review.
    Int J Cardiol. 2015;203:55-59.
    PubMed     Text format     Abstract available


  130. HUANG H, Zeng J, Kang Y, Huang H, et al
    Acute ischemia stroke: A rare and severe complication of ovarian hyperstimulation syndrome.
    Int J Cardiol. 2015;203:418-419.
    PubMed     Text format    


  131. BAIN LK, Myint PK, Jennings A, Lentjes MA, et al
    The relationship between dietary magnesium intake, stroke and its major risk factors, blood pressure and cholesterol, in the EPIC-Norfolk cohort.
    Int J Cardiol. 2015;196:108-14.
    PubMed     Text format     Abstract available


    September 2015
  132. ERGELEN M, Uyarel H, Goktekin O
    Interventional cardiologists in the treatment of acute ischemic stroke: New players in the game.
    Int J Cardiol. 2015;202:674-675.
    PubMed     Text format    


  133. KIM H, Ryu DR
    Difference in stroke incidence between Korean and Japanese patients initiating dialysis - era or ethnic effect?
    Int J Cardiol. 2015 Sep 25. pii: S0167-5273(15)30397.
    PubMed     Text format    


  134. NOZOE M, Kitamura Y, Kanai M, Kubo H, et al
    Physical activity in acute ischemic stroke patients during hospitalization.
    Int J Cardiol. 2015;202:624-626.
    PubMed     Text format    


  135. KAWADA T
    Risk of major cardiovascular events in patients with hemodialysis or peritoneal dialysis with special reference to stroke.
    Int J Cardiol. 2015 Sep 25. pii: S0167-5273(15)30302.
    PubMed     Text format    


  136. COLEMAN CI, Antz M, Ehlken B, Evers T, et al
    REal-LIfe Evidence of stroke prevention in patients with atrial Fibrillation - The RELIEF study.
    Int J Cardiol. 2015;203:882-884.
    PubMed     Text format    


  137. DURHEIM MT, Cyr DD, Lopes RD, Thomas LE, et al
    Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial.
    Int J Cardiol. 2015;202:589-594.
    PubMed     Text format     Abstract available


  138. MIRZADA N, Ladenvall P, Hansson PO, Eriksson P, et al
    Recurrent stroke in patients with patent foramen ovale: An observational prospective study of percutaneous closure of PFO versus non-closure.
    Int J Cardiol. 2015;195:293-9.
    PubMed     Text format     Abstract available


  139. KUMAR N, Venkatraman A, Garg N
    Seasonality in acute ischemic stroke related hospitalizations and case fatality rate in the United States.
    Int J Cardiol. 2015;195:134-5.
    PubMed     Text format    


  140. AHMAD Y, Nijjer S, Cook CM, El-Harasis M, et al
    A new method of applying randomised control study data to the individual patient: A novel quantitative patient-centred approach to interpreting composite end points.
    Int J Cardiol. 2015;195:216-24.
    PubMed     Text format     Abstract available


    August 2015
  141. YUAN M, Zhou HY, Xiao XL, Wang ZQ, et al
    Inflammatory bowel disease and risk of stroke: A meta-analysis of cohort studies.
    Int J Cardiol. 2015;202:106-109.
    PubMed     Text format    


  142. BLANN AD, Banerjee A, Lane DA, Torp-Pedersen C, et al
    Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study.
    Int J Cardiol. 2015;201:693-698.
    PubMed     Text format     Abstract available


  143. PASTORI D, Pignatelli P, Saliola M, Carnevale R, et al
    Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation.
    Int J Cardiol. 2015;201:513-516.
    PubMed     Text format     Abstract available


  144. PENG H, Chen M, Li G, Zhang M, et al
    Combination refusion therapy for a hemodynamically unstable patient with acute myocardial infarction complicated by acute ischemic stroke within a time window.
    Int J Cardiol. 2015;201:152-153.
    PubMed     Text format    


  145. CHENG CL, Chien HC, Lee CH, Lin SJ, et al
    Validity of in-hospital mortality data among patients with acute myocardial infarction or stroke in National Health Insurance Research Database in Taiwan.
    Int J Cardiol. 2015;201:96-101.
    PubMed     Text format     Abstract available


    July 2015
  146. BATUROVA MA, Lindgren A, Carlson J, Shubik YV, et al
    Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke.
    Int J Cardiol. 2015;199:248-252.
    PubMed     Text format     Abstract available


  147. XU T, Ke K
    C-reactive protein and ischemic stroke risk in general population: A dose-response meta-analysis of prospective studies.
    Int J Cardiol. 2015;190:264-7.
    PubMed     Text format    


  148. TONG Y, Lu Q, Zhang Y, Zhan F, et al
    Association of functional genetic variants in PPARgamma and PPARalpha encoding peroxisome proliferator-activated receptors with ischemic stroke in a unique Chinese population.
    Int J Cardiol. 2015;190:205-7.
    PubMed     Text format    


  149. ACAMPA M, Guideri F, Tassi R, Dello Buono D, et al
    P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism?
    Int J Cardiol. 2015;190:202-4.
    PubMed     Text format    


    June 2015
  150. LAI HC, Chien WC, Chung CH, Lee WL, et al
    Atrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of traffic accidents: A population-based cohort study.
    Int J Cardiol. 2015;197:133-139.
    PubMed     Text format     Abstract available


  151. PASTORI D, Farcomeni A, Bucci T, Cangemi R, et al
    Response to "Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality".
    Int J Cardiol. 2015;189:247-8.
    PubMed     Text format    


  152. AGARWAL S, Parashar A, Kumbhani DJ, Svensson LG, et al
    Comparative meta-analysis of balloon-expandable and self-expandable valves for transcatheter aortic valve replacement.
    Int J Cardiol. 2015;197:87-97.
    PubMed     Text format     Abstract available


  153. LASEK-BAL A, Gasior Z, Kowalewska-Twardela T, Urbanek T, et al
    New-onset atrial fibrillation in patients with elevated troponin I levels in the acute phase of stroke.
    Int J Cardiol. 2015;195:210-211.
    PubMed     Text format    


    May 2015
  154. CHEN JJ, Lin LY, Yang YH, Hwang JJ, et al
    Anti-platelet or anti-coagulant agent for prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation, is it necessary?
    Int J Cardiol. 2015;196:53.
    PubMed     Text format    


  155. BRAMBATTI M, Darius H, Oldgren J, Clemens A, et al
    Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial.
    Int J Cardiol. 2015;196:127-131.
    PubMed     Text format     Abstract available


  156. XIONG Q, Chen S, Senoo K, Proietti M, et al
    The CHADS and CHADS-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis.
    Int J Cardiol. 2015;195:237-242.
    PubMed     Text format     Abstract available


  157. LOSI MA, Izzo R, Stabile E, Sannino A, et al
    Diastolic dysfunction reduces stroke volume during daily's life activities in patients with severe aortic stenosis.
    Int J Cardiol. 2015;195:64-65.
    PubMed     Text format    


  158. POTLURI R, Wasim M, Markandey B, Kapour A, et al
    Length of hospital stay is shorter in South Asian patients with ischaemic stroke.
    Int J Cardiol. 2015;187:190-1.
    PubMed     Text format    


  159. WONG K, Sze S, Wong S, McSwiggan S, et al
    Myocardial fibrosis in stroke survivors.
    Int J Cardiol. 2015;187:138-40.
    PubMed     Text format    


  160. HURLEY C, Dai S, Sobieraj DM
    The impact of inpatient rivaroxaban versus warfarin on hospital-based outcomes when used for stroke prevention in patients with anticoagulant naive, new-onset nonvalvular atrial fibrillation.
    Int J Cardiol. 2015;192:1-2.
    PubMed     Text format    


    April 2015
  161. STERLING LH, Windle SB, Filion KB, Eisenberg MJ, et al
    Pharmacological management strategies for stroke prevention following transcatheter aortic valve replacement: A systematic review.
    Int J Cardiol. 2015;191:303-311.
    PubMed     Text format     Abstract available


  162. HSU CW, Huang YB, Chen CY
    Effect of antithrombotic and antiplatelet agents for ischemic stroke in atrial fibrillation patients with dialysis.
    Int J Cardiol. 2015;190:349.
    PubMed     Text format    


  163. LI M, Li K, Zhang XW, Hou WS, et al
    Habitual snoring and risk of stroke: A meta-analysis of prospective studies.
    Int J Cardiol. 2015;185:46-9.
    PubMed     Text format    


  164. WANG J, Gu C, Gao M, Yu W, et al
    Comparison of the incidence of postoperative neurologic complications after on-pump versus off-pump coronary artery bypass grafting in high-risk patients: A meta-analysis of 11 studies.
    Int J Cardiol. 2015;185:195-7.
    PubMed     Text format    


  165. MOSCHONAS IC, Goudevenos JA, Tselepis AD
    Protease-activated receptor-1 antagonists in long-term antiplatelet therapy. Current state of evidence and future perspectives.
    Int J Cardiol. 2015;185:9-18.
    PubMed     Text format     Abstract available


  166. VAN DOORN S, Hartman-Weide F, Geersing GJ, Oudega R, et al
    Reasons for non-adherence to practice guidelines on stroke prevention in patients with atrial fibrillation: A cross-sectional study in primary care.
    Int J Cardiol. 2015;187:525-526.
    PubMed     Text format    


  167. YILDIZ A, Soydinc S
    Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality.
    Int J Cardiol. 2015;184:512-3.
    PubMed     Text format    


  168. FINSTERER J, Zarrouk-Mahjoub S
    Management of juvenile stroke from noncompaction with muscular dystrophy.
    Int J Cardiol. 2015;184:371-2.
    PubMed     Text format    


  169. LI M, Zhang Z, Chen Y
    A comparison of stroke and coronary risks in Chinese and American.
    Int J Cardiol. 2015;184:251-3.
    PubMed     Text format    


  170. ZHANG E, Liu T, Li Z, Zhao J, et al
    High CHA2DS2-VASc score predicts left atrial thrombus or spontaneous echo contrast detected by transesophageal echocardiography.
    Int J Cardiol. 2015;184:540-2.
    PubMed     Text format    


  171. CARLSSON AC, Wandell P, Gasevic D, Sundquist J, et al
    Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care.
    Int J Cardiol. 2015;187:547-552.
    PubMed     Text format     Abstract available


    March 2015
  172. RUNEV NM, Dimitrov SM
    Management of stroke prevention in Bulgarian patients with non-valvular atrial fibrillation (BUL-AF Survey).
    Int J Cardiol. 2015;187:683-685.
    PubMed     Text format    


  173. CHEN CH, Chen MC, Gibbs H, Kwon SU, et al
    Antithrombotic treatment for stroke prevention in atrial fibrillation: The Asian agenda.
    Int J Cardiol. 2015;191:244-253.
    PubMed     Text format     Abstract available


  174. NAIROOZ R, Sardar P, Pino M, Aronow WS, et al
    Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation.
    Int J Cardiol. 2015;187:345-353.
    PubMed     Text format     Abstract available


  175. LIN HJ, Chen ST, Wu HY, Hsu HC, et al
    Urinary biomarkers of oxidative and nitrosative stress and the risk for incident stroke: a nested case-control study from a community-based cohort.
    Int J Cardiol. 2015;183:214-20.
    PubMed     Text format     Abstract available


  176. O'NEAL WT, Tanner RM, Efird JT, Baber U, et al
    Atrial fibrillation and incident end-stage renal disease: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    Int J Cardiol. 2015;185:219-223.
    PubMed     Text format     Abstract available


  177. DENTALI F, Botto GL, Gianni M, Ambrosino P, et al
    Efficacy and safety of direct oral anticoagulants in patients undergoing cardioversion for atrial fibrillation: A systematic review and meta-analysis of the literature.
    Int J Cardiol. 2015;185:72-77.
    PubMed     Text format     Abstract available


  178. WONG CX, Lee SW, Gan SW, Mahajan R, et al
    Underuse and overuse of anticoagulation for atrial fibrillation: A study in Indigenous and non-Indigenous Australians.
    Int J Cardiol. 2015;191:20-24.
    PubMed     Text format     Abstract available


  179. MCCALL SJ, Musgrave SD, Potter JF, Hale R, et al
    The shock index predicts acute mortality outcomes in stroke.
    Int J Cardiol. 2015;182:523-7.
    PubMed     Text format     Abstract available


  180. WANG J, Gu C, Gao M, Yu W, et al
    Adjunct coronary endarterectomy increases cerebrovascular accident after coronary artery bypass grafting: a meta-analysis of 17,600 patients.
    Int J Cardiol. 2015;182:79-81.
    PubMed     Text format    


    February 2015
  181. SZYMANSKI FM, Platek AE, Filipiak KJ
    Is obstructive sleep apnea associated with the risk of ischemic stroke in patients with atrial fibrillation?
    Int J Cardiol. 2015;184:481-482.
    PubMed     Text format    


  182. KALEMCI S, Altun I, Akin F, Biteker M, et al
    Obstructive sleep apnea and stroke risk in atrial fibrillation: Is there a correlation or not?
    Int J Cardiol. 2015;184C:306.
    PubMed     Text format    


  183. NOWAK R, Jaguszewski M, Fijalkowski M, Fijalkowska M, et al
    CMR to distinguish Takotsubo cardiomyopathy from myocardial infarction in acute course of ischemic stroke in a male patient.
    Int J Cardiol. 2015;184C:397-398.
    PubMed     Text format    


  184. SENOO K, Lane DA, Lip GY
    Stroke risk reduction with oral anticoagulation using CHA2DS2-VASc in a Japanese AF population: A modeling analysis.
    Int J Cardiol. 2015;181:247-54.
    PubMed     Text format     Abstract available


  185. KRAL M, Sanak D, Veverka T, Hutyra M, et al
    Troponin T: Correlation with location and volume of acute brain infarction.
    Int J Cardiol. 2015;181:127-32.
    PubMed     Text format     Abstract available


    January 2015
  186. RAPOSEIRAS-ROUBIN S, Garcia-Seara J, Cabanas-Grandio P, Abu-Assi E, et al
    Is safe to discontinue anticoagulation after successful ablation of atrial flutter?
    Int J Cardiol. 2015;201:631-632.
    PubMed     Text format    


  187. WINKEL P, Hilden J, Hansen JF, Kastrup J, et al
    Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial.
    Int J Cardiol. 2015;182C:459-465.
    PubMed     Text format     Abstract available


  188. MENON J, Vijayakumar N, Joseph JK, David PC, et al
    Below the poverty line and non-communicable diseases in Kerala: The Epidemiology of Non-communicable Diseases in Rural Areas (ENDIRA) study.
    Int J Cardiol. 2015;187:519-24.
    PubMed     Text format     Abstract available


    December 2014
  189. CHANG CC, Chiu CC, Chiang CH, Huang CC, et al
    Obstructive sleep apnea and the risk of ischemic stroke in patients with atrial fibrillation.
    Int J Cardiol. 2014;181C:144-146.
    PubMed     Text format    


    November 2014
  190. LIP GY, Wang KL, Chiang CE
    Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal.
    Int J Cardiol. 2014;180C:246-254.
    PubMed     Text format     Abstract available


  191. PASTORI D, Farcomeni A, Bucci T, Cangemi R, et al
    Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.
    Int J Cardiol. 2014;180C:1-5.
    PubMed     Text format     Abstract available


  192. YEH PS, Yang CM, Lin SH, Wang WM, et al
    Antithrombotic therapy for atrial fibrillation in patients with acute ischemic stroke or transient ischemic attack.
    Int J Cardiol. 2014;179C:288-291.
    PubMed     Text format    


  193. KORNEJ J, Lobe S, Efimova E, Husser D, et al
    NT-proBNP in "low risk" patients with atrial fibrillation.
    Int J Cardiol. 2014 Nov 6. pii: S0167-5273(14)02188.
    PubMed     Text format    


    October 2014
  194. VASSILIOU V, Rana B, Goddard M, Braganza D, et al
    Acute myocardial infarction and acute stroke: Between a rock and a hard place.
    Int J Cardiol. 2014;180C:214-215.
    PubMed     Text format    


  195. CHEN JJ, Lin LY, Yang YH, Hwang JJ, et al
    Anti-platelet or anti-coagulant agent for the prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation-A nation-wide database analyses.
    Int J Cardiol. 2014;177:1008-1011.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: